EP Patent

EP1342447A2 — Endoscopic capsule

Assigned to Olympus Corp · Expires 2003-09-10 · 23y expired

What this patent protects

A capsule endoscope is disclosed that includes means for illuminating an object, means for imaging the object, and a transparent cover having a center of curvature. The transparent cover covers the illumination means and the imaging means, and the imaging means includes an object…

USPTO Abstract

A capsule endoscope is disclosed that includes means for illuminating an object, means for imaging the object, and a transparent cover having a center of curvature. The transparent cover covers the illumination means and the imaging means, and the imaging means includes an objective optical system and an image detecting element. The illumination means is positioned relative to the image detecting element, as viewed axially from the object side of the capsule endoscope, so that an area that is symmetrically positioned about the optical axis of the objective optical system from a light emitting area of the illumination means overlaps an area of the image detecting element, but does not overlap any areas of the image detecting element that are used for image detection.

Drugs covered by this patent

Patent Metadata

Patent number
EP1342447A2
Jurisdiction
EP
Classification
—
Expires
2003-09-10
Drug substance claim
No
Drug product claim
No
Assignee
Olympus Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.